Future Directions in CLL Treatment
Lori A. Leslie, MD, and Hoshiyuki Iida, APN, offer closing thoughts on the future treatment landscape of chronic lymphocytic leukemia.
Hoshiyuki Iida Hoshi Iida Gloria Leslie Chronic Lymphocytic Leukemia Minimal Residual Disease Btk Inhibitors
Source: curetoday.com